Effects of Metformin on COVID-19 Patients with Type 2 Diabetes: A Retrospective Study

References

• Apicella M, Campopiano MC, Mantuano M, et al. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8(9):782–792. doi:10.1016/S2213-8587(20)30238-2
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–2059. doi:10.1001/jama.2020.6775
   PubMed Web of Science ®Google Scholar
• Zhu L, She ZG, Cheng X, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31(6):1068–77.e3. doi:10.1016/j.cmet.2020.04.021
   PubMed Web of Science ®Google Scholar
• Targher G, Mantovani A, Wang XB, et al. Patients with diabetes are at higher risk for severe illness from COVID-19. Diabetes Metab. 2020;46(4):335–337. doi:10.1016/j.diabet.2020.05.001
   PubMed Web of Science ®Google Scholar
• Singh AK, Khunti K. Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: a narrative review. Diabetes Res Clin Pract. 2020;165:108266. doi:10.1016/j.diabres.2020.108266
   PubMed Web of Science ®Google Scholar
• Buse JB, Wexler DJ, Tsapas A, et al. 2019 update to: management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2020;63(2):221–228. doi:10.1007/s00125-019-05039-w
   PubMed Web of Science ®Google Scholar
• Cheng X, Liu YM, Li H, et al. Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with COVID-19 and Pre-existing type 2 diabetes. Cell Metab. 2020;32(4):537–47.e3. doi:10.1016/j.cmet.2020.08.013
   PubMed Web of Science ®Google Scholar
• Hashemi P, Pezeshki S. Repurposing metformin for covid-19 complications in patients with type 2 diabetes and insulin resistance. Immunopharmacol Immunotoxicol. 2021;43(3):265–270. doi:10.1080/08923973.2021.1925294
   PubMed Web of Science ®Google Scholar
• Sharma S, Ray A, Sadasivam B. Metformin in COVID-19: a possible role beyond diabetes. Diabetes Res Clin Pract. 2020;164:108183. doi:10.1016/j.diabres.2020.108183
   PubMed Web of Science ®Google Scholar
• Zhang J, Dong J, Martin M, et al. AMP-activated protein kinase phosphorylation of angiotensin-converting enzyme 2 in endothelium mitigates pulmonary hypertension. Am J Respir Crit Care Med. 2018;198(4):509–520. doi:10.1164/rccm.201712-2570OC
   PubMed Web of Science ®Google Scholar
• Bramante C. The COVID-OUT study: a randomized, double-blind, placebo-controlled trial of metformin for the treatment of COVID-19 sequelae. medRxiv; 2021.
   Google Scholar
• Yu B, Li C, Sun Y, et al. Insulin treatment is associated with increased mortality in patients with COVID-19 and type 2 diabetes. Cell Metab. 2021;33(1):65–77.e2. doi:10.1016/j.cmet.2020.11.014
   PubMed Web of Science ®Google Scholar
• Sancho-López A, Caballero-Bermejo AF, Ruiz-Antorán B, et al. Efficacy and safety of sarilumab in patients with COVID19 pneumonia: a randomized, phase III clinical trial (SARTRE study). Infect Dis Ther. 2021;2021:1–14.
   Google Scholar
• Zhang XJ, Qin JJ, Cheng X, et al. In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19. Cell Metab. 2020;32(2):176–87.e4. doi:10.1016/j.cmet.2020.06.015
   PubMed Web of Science ®Google Scholar
• Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020;395(10231):1225–1228. doi:10.1016/S0140-6736(20)30627-9
   PubMed Web of Science ®Google Scholar
• Iacobellis G, Penaherrera CA, Bermudez LE, et al. Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes. Diabetes Res Clin Pract. 2020;164:108185. doi:10.1016/j.diabres.2020.108185
   PubMed Web of Science ®Google Scholar
• Bornstein SR, Rubino F, Khunti K, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8(6):546–550. doi:10.1016/S2213-8587(20)30152-2
   PubMed Web of Science ®Google Scholar
• Cariou B, Hadjadj S, Wargny M, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020;63(8):1500–1515. doi:10.1007/s00125-020-05180-x
   PubMed Web of Science ®Google Scholar
• Crouse AB, Grimes T, Li P, et al. Metformin use is associated with reduced mortality in a diverse population with COVID-19 and diabetes. Front Endocrinol. 2020;11:600439. doi:10.3389/fendo.2020.600439
   PubMed Web of Science ®Google Scholar
• Nguyen NN, Ho DS, Nguyen HS, et al. Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: a meta-analysis. Metabolism. 2022;131:155196. doi:10.1016/j.metabol.2022.155196
   PubMed Web of Science ®Google Scholar
• Wang J, Cooper JM, Gokhale K, et al. Association of metformin with susceptibility to COVID-19 in people with type 2 diabetes. J Clin Endocrinol Metab. 2021;106(5):1255–1268. doi:10.1210/clinem/dgab067
   PubMed Web of Science ®Google Scholar
• Bramante CT, Huling JD, Tignanelli CJ, et al. Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19. N Engl J Med. 2022;387(7):599–610. doi:10.1056/NEJMoa2201662
   PubMed Web of Science ®Google Scholar
• Ceriello A. Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory. Diabetes Res Clin Pract. 2020;163(163):108186. doi:10.1016/j.diabres.2020.108186
   PubMedGoogle Scholar
• Roca-Ho H, Riera M, Palau V, et al. Characterization of ACE and ACE2 expression within different organs of the NOD mouse. Int J Mol Sci. 2017;18(3):563. doi:10.3390/ijms18030563
   PubMed Web of Science ®Google Scholar
• Ursini F, Ciaffi J, Landini MP, et al. COVID-19 and diabetes: is metformin a friend or foe? Diabetes Res Clin Pract. 2020;164:108167. doi:10.1016/j.diabres.2020.108167
   PubMed Web of Science ®Google Scholar